Atgam

Atgam (Anti-T Lymphocyte Immunoglobulin) is an intravenous medication used to suppress immune responses. It is commonly prescribed for organ transplant patients to prevent rejection.

Atgam is primarily used to suppress the immune system in patients who have undergone organ transplants. It helps prevent the body from rejecting the transplanted organ by targeting T lymphocytes, which are a type of white blood cell involved in immune responses. This medication is often used in conjunction with other immunosuppressive therapies to enhance effectiveness.

Common effects of Atgam may include fever, chills, and general discomfort during or shortly after administration. Some patients may experience allergic reactions, which can range from mild to severe. It is important to monitor for signs of infection, as the medication can weaken the immune system.

Atgam should be administered under the supervision of a healthcare professional. Patients should be monitored for signs of allergic reactions or infections. It is crucial to follow the prescribed dosage and administration schedule to minimize risks. Inform your healthcare provider about any pre-existing conditions or allergies before starting treatment.

Atgam may interact with other medications that suppress the immune system, increasing the risk of infections. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain over-the-counter drugs may also affect the body's response to Atgam.